European Response

Showing 693 articles
Business

Gilead Sciences Bets on Precision Oncology to Power Next Growth Phase

Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.

World

Whistleblower Complaint Against Intelligence Chief Gabbard Stalled for Months, Sparking Bipartisan Scrutiny

A complaint alleging misconduct by Director of National Intelligence Tulsi Gabbard has been withheld from congressional oversight committees for eight months, her office citing an extended legal review. The delay, disputed by the complainant's attorney, raises questions about transparency and adherence to whistleblower protection laws within the nation's top intelligence office.